CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 172 filers reported holding CARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $277,622 | -48.1% | 165,252 | -12.6% | 0.00% | – |
| Q2 2023 | $535,364 | -73.1% | 189,175 | -53.3% | 0.00% | – |
| Q1 2023 | $1,989,196 | -54.2% | 405,132 | +0.1% | 0.00% | -100.0% |
| Q4 2022 | $4,345,946 | +7.7% | 404,651 | -6.2% | 0.00% | 0.0% |
| Q3 2022 | $4,037,000 | +11.2% | 431,373 | +8.5% | 0.00% | 0.0% |
| Q2 2022 | $3,632,000 | -31.9% | 397,682 | -9.4% | 0.00% | 0.0% |
| Q1 2022 | $5,337,000 | +0.5% | 439,181 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $5,313,000 | -16.9% | 436,114 | +5.3% | 0.00% | 0.0% |
| Q3 2021 | $6,397,000 | +10.0% | 414,070 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $5,814,000 | +57.9% | 407,474 | +140.2% | 0.00% | 0.0% |
| Q1 2021 | $3,682,000 | +36.6% | 169,627 | -4.8% | 0.00% | 0.0% |
| Q4 2020 | $2,696,000 | +17.0% | 178,248 | -1.6% | 0.00% | 0.0% |
| Q3 2020 | $2,304,000 | -26.7% | 181,124 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $3,142,000 | +33.1% | 183,748 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $2,361,000 | -17.5% | 178,785 | +0.7% | 0.00% | 0.0% |
| Q4 2019 | $2,862,000 | -21.0% | 177,624 | -10.3% | 0.00% | 0.0% |
| Q3 2019 | $3,621,000 | +18.7% | 198,004 | +39.6% | 0.00% | 0.0% |
| Q2 2019 | $3,050,000 | +8.2% | 141,841 | -1.3% | 0.00% | 0.0% |
| Q1 2019 | $2,820,000 | +48.9% | 143,706 | -1.3% | 0.00% | 0.0% |
| Q4 2018 | $1,894,000 | -44.4% | 145,658 | +2.4% | 0.00% | 0.0% |
| Q3 2018 | $3,407,000 | +38.4% | 142,244 | +10.7% | 0.00% | 0.0% |
| Q2 2018 | $2,461,000 | +54.7% | 128,472 | -0.0% | 0.00% | – |
| Q1 2018 | $1,591,000 | +4.5% | 128,525 | +3.2% | 0.00% | – |
| Q4 2017 | $1,523,000 | -8.3% | 124,502 | +2.6% | 0.00% | – |
| Q3 2017 | $1,661,000 | -39.3% | 121,307 | -31.8% | 0.00% | -100.0% |
| Q2 2017 | $2,735,000 | +5.5% | 177,766 | +26.1% | 0.00% | 0.0% |
| Q1 2017 | $2,593,000 | +90.1% | 140,997 | -4.0% | 0.00% | – |
| Q4 2016 | $1,364,000 | +107.3% | 146,852 | +86.7% | 0.00% | – |
| Q3 2016 | $658,000 | +53.4% | 78,669 | -11.9% | 0.00% | – |
| Q2 2016 | $429,000 | -33.0% | 89,299 | -13.3% | 0.00% | – |
| Q1 2016 | $640,000 | -61.1% | 102,992 | +5.4% | 0.00% | – |
| Q4 2015 | $1,647,000 | +75.6% | 97,703 | +48.8% | 0.00% | – |
| Q3 2015 | $938,000 | +27.8% | 65,653 | +8.7% | 0.00% | – |
| Q2 2015 | $734,000 | +207.1% | 60,394 | +154.0% | 0.00% | – |
| Q1 2015 | $239,000 | +2.1% | 23,773 | +1.3% | 0.00% | – |
| Q4 2014 | $234,000 | -7.1% | 23,460 | -21.8% | 0.00% | – |
| Q3 2014 | $252,000 | -68.8% | 30,010 | -36.7% | 0.00% | – |
| Q2 2014 | $808,000 | +229.8% | 47,442 | +261.2% | 0.00% | – |
| Q1 2014 | $245,000 | – | 13,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
| RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
| DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
| Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
| Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
| FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |